APA

Katz S. I., Zhou L., Chao G., Smith C. D., Ferrara T., Wang W., Dicker D. T. & El-Deiry W. S. (20100806). Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma. : Cancer biology & therapy.

Chicago

Katz Sharyn I, Zhou Lanlan, Chao Grace, Smith Charles D, Ferrara Thomas, Wang Wenge, Dicker David T and El-Deiry Wafik S. 20100806. Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma. : Cancer biology & therapy.

Harvard

Katz S. I., Zhou L., Chao G., Smith C. D., Ferrara T., Wang W., Dicker D. T. and El-Deiry W. S. (20100806). Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma. : Cancer biology & therapy.

MLA

Katz Sharyn I, Zhou Lanlan, Chao Grace, Smith Charles D, Ferrara Thomas, Wang Wenge, Dicker David T and El-Deiry Wafik S. Sorafenib inhibits ERK1/2 and MCL-1(L) phosphorylation levels resulting in caspase-independent cell death in malignant pleural mesothelioma. : Cancer biology & therapy. 20100806.